Success Metrics

Clinical Success Rate
93.7%

Based on 281 completed trials

Completion Rate
94%(281/300)
Active Trials
141(24%)
Results Posted
10%(29 trials)
Terminated
19(3%)

Phase Distribution

Ph phase_1
11
2%
Ph early_phase_1
2
0%
Ph phase_2
8
1%
Ph phase_3
16
3%
Ph phase_4
17
3%
Ph not_applicable
245
42%

Phase Distribution

13

Early Stage

8

Mid Stage

33

Late Stage

Phase Distribution299 total trials
Early Phase 1First-in-human
2(0.7%)
Phase 1Safety & dosage
11(3.7%)
Phase 2Efficacy & side effects
8(2.7%)
Phase 3Large-scale testing
16(5.4%)
Phase 4Post-market surveillance
17(5.7%)
N/ANon-phased studies
245(81.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.6%

281 of 310 finished

Non-Completion Rate

9.4%

29 ended early

Currently Active

141

trials recruiting

Total Trials

590

all time

Status Distribution
Active(195)
Completed(281)
Terminated(29)
Other(85)

Detailed Status

Completed281
Recruiting134
unknown85
Not yet recruiting52
Terminated19
Withdrawn10

Development Timeline

Analytics

Development Status

Total Trials
590
Active
141
Success Rate
93.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (0.7%)
Phase 111 (3.7%)
Phase 28 (2.7%)
Phase 316 (5.4%)
Phase 417 (5.7%)
N/A245 (81.9%)

Trials by Status

terminated193%
active_not_recruiting71%
enrolling_by_invitation20%
withdrawn102%
not_yet_recruiting529%
recruiting13423%
completed28148%
unknown8514%

Recent Activity

Clinical Trials (590)

Showing 20 of 590 trialsScroll for more
NCT06327308Phase 1

Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.

Recruiting
NCT04272515Not Applicable

Molecular Characterization for Understanding Biliary Atresia

Recruiting
NCT04590261Not Applicable

Myeloid Cells in Patients With Covid-19 Pneumonia

Withdrawn
NCT07702630

ABCG8, UGT1A1 and Gallstone Disease After Bariatric Surgery

Not Yet Recruiting
NCT07398170Not Applicable

Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study

Recruiting
NCT07701070

SHIELD: Surveillance of HR+/HER2- : Implementing ESR1m Long-term Monitoring and Detection in 1L aBC

Not Yet Recruiting
NCT07178847Not Applicable

cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas

Recruiting
NCT04067674

Septic Shock-induced Immunosuppression

Recruiting
NCT06304233

The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

Active Not Recruiting
NCT03739775Not Applicable

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

Completed
NCT05806697Not Applicable

Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study

Recruiting
NCT04353323

COVID 19-Caregivers IGg Seroconversion

Withdrawn
NCT07668674Phase 2

Functional Brain MRI to Understand Pain Phenotypes in Knee Osteoarthritis

Not Yet Recruiting
NCT06780722

Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure

Recruiting
NCT07665554Not Applicable

Advancing Neurogenetic Diagnoses Through Long-Read Sequencing

Not Yet Recruiting
NCT07207304Not Applicable

Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes

Completed
NCT04429594Not Applicable

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

Recruiting
NCT07647978

Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period

Not Yet Recruiting
NCT02615951Not Applicable

Characterization of Breg Cells

Completed
NCT04807023

Decompensation of Cirrhosis and Iron Metabolism

Completed

Drug Details

Intervention Type
OTHER
Total Trials
590